REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Jfs Pharm S. R. O. (Slovakia)

Main Activities: Direct Selling Establishments | Other Direct Selling Establishments
Secondary Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Other Commercial and Industrial Machinery and Equipment Rental and Leasing | Management Consulting Services | Research and Development in the Social Sciences and Humanities | Advertising Agencies | Marketing Research and Public Opinion Polling
Full name: Jfs Pharm S. R. O. Profile Updated: October 21, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Jfs Pharm S. R. O. is based in Slovakia, with the head office in Sebechleby. It operates in the Direct Selling Establishments industry. Jfs Pharm S. R. O. was incorporated on August 16, 2011. There was a net sales revenue increase of 29.77% reported in Jfs Pharm S. R. O.’s latest financial highlights for 2024. Its’ total assets recorded a growth of 32.18%. In, 2024, the company’s net profit margin decreased by 1.28%.

Headquarters
Sebechleby, 214
Sebechleby; Postal Code: 96266

Contact Details: Purchase the Jfs Pharm S. R. O. report to view the information.

Basic Information
Registered Capital:
Purchase the Jfs Pharm S. R. O. report to view the information.
Financial Auditors:
Purchase the Jfs Pharm S. R. O. report to view the information.
Incorporation Date:
August 16, 2011
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Jfs Pharm S. R. O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
29.77%▲
Total operating revenue
29.92%▲
Operating profit (EBIT)
-2.12%▼
EBITDA
0.89%▲
Net Profit (Loss) for the Period
-3.59%▼
Total Assets
32.18%▲
Total Equity
51.28%▲
Operating Profit Margin (ROS)
-1.58%▼
Net Profit Margin
-1.28%▼
Return on Equity (ROE)
-19.29%▼
Quick Ratio
0.36%▲
Cash Ratio
0.34%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo